VOXZOGO is the only approved treatment for children with achondroplasia starting at birth, with over 10 years of clinical research demonstrating the long-term benefit on complications associated with achondroplasia
Two ARUP Medical Directors Receive Career Achievement Awards
As gaps in early detection persist, a 45-second voice analysis offers a new way to identify signals of stress, anxiety, and depression during Mental Health Awareness Month
What to Know About the Reauthorized SBIR/STTR Grant Programs
H.C. Wainwright Initiates Coverage on SINTX Technologies with Buy Rating, Highlighting Silicon Nitride Platform Opportunity
Calycia Bioscience Wins People’s Choice Award at Altitude Lab Demo Day 2026
Freyya Wins San Antonio TechFuel 2026 Competition
James LeVoy Sorenson Center for Medical Innovation Grand Opening, Ribbon Cutting
PhotoPharmics will be attending the American Academy of Neurology Annual Meeting (AAN) in Chicago, April 18-22.
Myriad Genetics Expands Access for MyChoice Test to Prostate Cancer Patients in Japan
Freyya Selected as Finalist for Tech Fuel 2026
The “White Glove” Delivery: How a Joke Landed Me in Iceland